Amedeo's Top 20

Amedeo Smart

Independent Medical Education


08 September 2014

Multidisciplinary Journal Club

  1. Loberg M, Kalager M, Holme O, Hoff G, et al.
    Long-term colorectal-cancer mortality after adenoma removal.
    N Engl J Med 2014;371:799-807.

  1. Simes J, Becattini C, Agnelli G, Eikelboom JW, et al.
    Aspirin for the Prevention of Recurrent Venous Thromboembolism: The INSPIRE Collaboration.
    Circulation 2014.

  2. Obeso JA, Rodriguez-Oroz MC, Stamelou M, Bhatia KP, et al.
    The expanding universe of disorders of the basal ganglia.
    Lancet 2014;384:523-31.

  3. Meddings J , Rogers MA, Macy M, Saint S, et al.
    Systematic review and meta-analysis: reminder systems to reduce catheter-associated urinary tract infections and urinary catheter use in hospitalized patients.
    Clin Infect Dis 2010;51:550-60.

  4. Tam CS, Seymour JF.
    A new prognostic score for CLL.
    Blood 2014;124:1-2.

  1. Kahl BS, Hong F, Williams ME, Gascoyne RD, et al.
    Rituximab Extended Schedule or Re-Treatment Trial for Low-Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402.
    J Clin Oncol 2014.

  2. Petrich AM, Gandhi M, Jovanovic B, Castillo JJ, et al.
    Impact of induction regimen and stem cell transplantation on outcomes in patients with double hit lymphoma: a large multicenter retrospective analysis.
    Blood 2014.

  3. Makris UE, Abrams RC, Gurland B, Reid MC, et al.
    Management of persistent pain in the older patient: a clinical review.
    JAMA 2014;312:825-36.

  4. Sieber BA, Landis S, Koroshetz W, Bateman R, et al.
    Prioritized Research Recommendations from NINDS Parkinson's Disease 2014.
    Ann Neurol 2014.

  5. Lammers WJ, van Buuren HR, Hirschfield GM, Janssen HL, et al.
    Levels of Alkaline Phosphatase and Bilirubin are Surrogate Endpoints of Outcomes of Patients with Primary Biliary Cirrhosis - an International Follow-up Study.
    Gastroenterology 2014.

  1. Dumonceau JM, Andriulli A, Elmunzer BJ, Mariani A, et al.
    Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Updated June 2014.
    Endoscopy 2014.

  2. Menge T, Stuve O, Kieseier BC, Hartung HP, et al.
    Alemtuzumab: the advantages and challenges of a novel therapy in MS.
    Neurology 2014;83:87-97.

  3. Yusuf S, Rangarajan S, Teo K, Islam S, et al.
    Cardiovascular risk and events in 17 low-, middle-, and high-income countries.
    N Engl J Med 2014;371:818-27.

  4. Petrides G, Malur C, Braga RJ, Bailine SH, et al.
    Electroconvulsive Therapy Augmentation in Clozapine-Resistant Schizophrenia: A Prospective, Randomized Study.
    Am J Psychiatry 2014.

  5. O'Connor P, Goodman A, Kappos L, Lublin F, et al.
    Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study.
    Neurology 2014;83:78-86.

  1. Galli L, Spagnuolo V, Poli A, Salpietro S, et al.
    Use of statins and risk of AIDS-defining and non-AIDS defining malignancies among HIV-1 infected patients on antiretroviral therapy.
    AIDS 2014.

  2. de Azambuja E, Procter MJ, van Veldhuisen DJ, Agbor-Tarh D, et al.
    Trastuzumab-associated cardiac events at 8 years of median follow-up in the Herceptin Adjuvant trial (BIG 1-01).
    J Clin Oncol 2014;32:2159-65.

  3. Colombel Md JF, Sandborn Md WJ, Ghosh Md S, Wolf Md DC, et al.
    Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3.
    Am J Gastroenterol 2014.

  4. Verbelen H, Gebruers N, Beyers T, De Monie AC, et al.
    Breast edema in breast cancer patients following breast-conserving surgery and radiotherapy: a systematic review.
    Breast Cancer Res Treat 2014.

  5. Duarte RF, Sanchez-Ortega I, Cuesta I, Arnan M, et al.
    Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective anti-mold prophylaxis.
    Clin Infect Dis 2014.


more..


Privacy Policy